JNJ
What one share of Johnson & Johnson holds
Pharmaceutical Preparations
Johnson & Johnson and its subsidiaries (the Company) have approximately 138,200 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world.
Johnson & Johnson’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-09-27; the balance sheet is as of 2026-09-27.
| Sales | $40.63 |
|---|---|
| Profit | $6.58 |
| Capex (buildings and equipment) | $2.28 |
| Free cash flow | $8.42 |
| Dividends | $5.28 |
| Cash and investments | $7.16 |
| Debt | $18.55 |
| Book value | $33.87 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $25.78 | $5.93 | $1.16 | $5.57 | $3.15 | $25.95 |
| 2017 | $27.85 | $0.47 | $1.19 | $6.48 | $3.32 | $22.42 |
| 2018 | $29.90 | $5.61 | $1.34 | $6.79 | $3.54 | $22.44 |
| 2019 | $30.57 | $5.63 | $1.30 | $7.42 | $3.75 | $22.57 |
| 2020 | $30.92 | $5.51 | $1.25 | $7.56 | $3.98 | $24.07 |
| 2021 | $29.45 | $7.81 | $1.37 | $7.39 | $4.19 | $28.15 |
| 2022 | $30.03 | $6.73 | $1.50 | $6.45 | $4.45 | $29.49 |
| 2023 | $33.26 | $13.73 | $1.77 | $7.13 | $4.70 | $28.55 |
| 2024 | $36.56 | $5.79 | $1.82 | $8.17 | $4.91 | $29.69 |
| 2025 | $38.77 | $11.03 | $1.99 | $8.11 | $5.14 | $33.84 |